Two Sigma Investments, LP Fennec Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$7.27 - $9.82 $340,301 - $459,664
-46,809 Reduced 77.54%
13,561 $119,000
Q1 2023

May 15, 2023
SELL
$7.38 - $10.35 $201,481 - $282,565
-27,301 Reduced 31.14%
60,370 $502,000
Q4 2022

Feb 14, 2023
BUY
$7.63 - $10.22 $668,929 - $895,997
87,671 New
87,671 $841,000
Q3 2020

Nov 16, 2020
SELL
$5.19 - $10.17 $71,767 - $140,630
-13,828 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$5.43 - $9.39 $75,086 - $129,844
13,828 New
13,828 $115,000

Others Institutions Holding FENC

# of Institutions
64
Shares Held
14.7M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $165M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email